Saving changes...

Done

Error

2018 ACCP Webinar June | How to be a GREAT Journal Peer Reviewer

2018 ACCP Webinar June | How to be a GREAT Journal Peer Reviewer

2018 ACCP Webinar June | How to be a GREAT Journal Peer Reviewer

Joseph S. Bertino Jr., Pharm.D., FCP, FCCP, David J. Greenblatt MD, FCP and  Joan Korth-Bradley, Pha
Joseph S. Bertino Jr., Pharm.D., FCP, FCCP, David J. Greenblatt MD, FCP and Joan Korth-Bradley, Pha
on behalf of American College of Clinical Pharmacology

$20.00 $ 20.00 $ 20.00

$ 20.00 $ 20.00 $ 20.00
$ 20.00 $ 20.00 $ 20.00
Normal Price: $20.00 $20.00

Review:

Launch date: 18 Jul 2018
Expiry Date:

Last updated: 16 Apr 2019

Reference: 190965

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

You have null days left.

Description

At the completion of this webinar participants will have a strong understanding and the skills to properly review a scientific manuscript, a professional competency applicable to journal peer reviewing across professions. Topics to be covered include: why one should serve as peer reviewer; the purpose of manuscript reviews; aspects of a great review; when to decline a review; confidentiality; a technical guide for reviews for each section of the manuscript; and writing the review.

Objectives

Describe why the peer review process is important
On completion of this course, the learner will be able to describe why the peer review process is important;
Explain how to review various sections of a scientific manuscript
On completion of this course, the learner will be able to explain how to review various sections of a scientific manuscript
Identify elements of writing a review that will be of benefit to the authors and to the Editor of the Journal.
On completion of this course, the learner will be able to identify elements of writing a review that will be of benefit to the authors and to the Editor of the Journal.
Joseph S. Bertino Jr., Pharm.D., FCP, FCCP, David J. Greenblatt MD, FCP and  Joan Korth-Bradley, Pha

Author Information Play Video Bio

Joseph S. Bertino Jr., Pharm.D., FCP, FCCP, David J. Greenblatt MD, FCP and Joan Korth-Bradley, Pha
on behalf of American College of Clinical Pharmacology

Joseph S. Bertino Jr., Pharm.D., FCP, FCCP -
Joseph is currently a Principal at Bertino Consulting, located in Schenectady, NY. He is an Associate Professor of Pharmacology at the College of Physicians and Surgeons, Columbia University, New York, NY and an adjunct Associate Professor at the University at Buffalo School of Pharmacy. He is also an Honorary Professor, Hanoi University of Pharmacy and a Distinguished Professor of the Hai Phong University of Medicine and Pharmacy.

Dr. Bertino received his B.S.Pharmacy and Pharm.D. degrees from the University at Buffalo in Buffalo, NY, USA. He has published over 100 original research papers, review articles and book chapters and a textbook of pharmacogenomics. His publications have included work in the area of antimicrobial pharmacokinetics, pharmacodynamics and toxicity, drug-drug interactions, general clinical pharmacology, vaccine pharmacology and the application of pharmacogenetics and pharmacogenomics to the drug development process.

He serves on the Editorial Board of The European Journal of Clinical Pharmacology and Antimicrobial Agents and Chemotherapy. Dr. Bertino has served on the Food and Drug Administration’s Antiinfective and Antiviral Advisory Committees. He also serves as the Editor-in-Chief of the Journal of Clinical Pharmacology.


David J. Greenblatt MD, FCP -
Dr. Greenblatt has been on the Faculty of Tufts University School of Medicine and the Staff of Tufts Medical Center since 1979. He holds the Louis Lasagna, M. D., Endowed Professorship at Tufts University School of Medicine, in the Department of Immunology (formerly the Department of Pharmacology and Experimental Therapeutics), and is a senior faculty member in the Graduate Program in Pharmacology & Experimental Therapeutics at the Sackler School of Graduate Biomedical Sciences at Tufts University. He also holds appointments as Professor of Psychiatry, Medicine, and Anesthesia, Tufts University School of Medicine. He has previously served as Chair of the Department of Pharmacology and Experimental Therapeutics at Tufts University School of Medicine, Program Director and Associate Program Director of the institution’s Clinical/Translational Research Center (formerly the General Clinical Research Center), and Chair of the Institutional Review Board. He is Editor-in-Chief of Clinical Pharmacology in Drug Development, operated by the American College of Clinical Pharmacology. He also is Co-Editor-in-Chief, with Dr. Richard I. Shader, of the Journal of Clinical Psychopharmacology,


Joan Korth-Bradley, PharmD, PhD, FCP -
Joan Korth-Bradley is Senior Director, Clinical Pharmacology at Pfizer Inc where she has worked since 1991. She received her B.Sc.Phm. from the University of Toronto, her Pharm.D. from the University of Minnesota and her Ph.D. from the University of Texas at Austin. She also completed a residency in hospital pharmacy at the Ottawa General Hospital and a post-PharmD fellowship in pediatric clinical pharmacy at the University of Texas at Austin/Brackenridge Hospital, Austin. She serves on the editorial board of the Clinical Pharmacology and Therapeutics, Clinical and Translational Science, and the Journal of Clinical Pharmacology. Joan also serves as a peer reviewer for several other clinical therapeutics and pharmacology journals. In addition, she has served as a leader in the American Association of Pharmaceutical Scientists (CPTR Section), American College of Clinical Pharmacy (PK PRN, Industrial Pharmacy PRN), the American College of Clinical Pharmacology (Regent), and the American Society of Clinical Pharmacology and Therapeutics (TPM Network). Her work includes participating as a member of multi-disciplinary development teams working in rare diseases, including hemophilia and growth hormone deficiency. Previously, she supported anti-infectives and anti-inflammatories as well as life-cycle management activities and market support for a variety of products. Her current research interests are the application of modeling and simulation of pharmacokinetic and pharmacodynamic data in drug development of hemophilia replacement products as well as for drugs in children and other special populations.

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Accreditation Council for Continuing Medical Education (ACCME)
  • 1.00 Credits

Faculty and Disclosures

Joseph S. Bertino Jr, PharmD, FCP, FCCP, Editor-in-Chief The Journal of Clinical Pharmacology, who developed the continuing education portion of this activity

Joseph S. Bertino Jr, PharmD, FCP, FCCP, Editor-in-Chief The Journal of Clinical Pharmacology, who developed the continuing education portion of this activity

Has nothing to disclose.
David J. Greenblatt MD, FCP, Editor-in-Chief Clinical Pharmacology in Drug Development, discloses a financial relationship with Alkermes Inc

David J. Greenblatt MD, FCP, Editor-in-Chief Clinical Pharmacology in Drug Development, discloses a financial relationship with Alkermes Inc

Discloses a financial relationship with Alkermes Inc which is not related to this topic.
Joan Korth-Bradley, PharmD, PhD, FCP, Senior Director, Clinical Pharmacology, Pfizer Inc,

Joan Korth-Bradley, PharmD, PhD, FCP, Senior Director, Clinical Pharmacology, Pfizer Inc,

Discloses a financial relationship with Pfizer Inc which is not related to this topic.
Prithpal Matreja MBBS, MD,, Doctor of Clinical Pharmacology, TMMCRC, TMU, Moradabad India

Prithpal Matreja MBBS, MD,, Doctor of Clinical Pharmacology, TMMCRC, TMU, Moradabad India

Has nothing to disclose.

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error